Atossa CEO Bets Big on Own Stock, Grants Huge Options Package Amid Market Volatility
Atossa Therapeutics’ CEO buys 325k shares and 950k options, boosting insider confidence despite a 52‑week low, signaling potential upside as the company aims for a clinical breakthrough.
3 minutes to read